ESC 365 - Beta-blockers in diabetes with stable coronary heart disease- a cause for concern?

ESC Premium Access

Beta-blockers in diabetes with stable coronary heart disease- a cause for concern?

Session: Diabetes and the heart

Topic: Pharmacotherapy

Speaker: Assistant Professor A. Malik (Valhalla, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Assistant Professor Aaqib H Malik

New York Medical College, Valhalla (United States of America)

0 follower

6 more presentations in this session

Peripheral neuropathy and diastolic function are associated with adverse cardiovascular outcome in patients with type 1 diabetes mellitus: results from the thousand & 1 study

Speaker: Doctor M. Jensen (Herlev, DK)

Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes: data from the Look AHEAD trial.

Speaker: Miss T. de Vries (Utrecht, NL)

Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment

Speaker: Doctor I. Ikonomidis (Athens, GR)

The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes

Speaker: Doctor A. Mader (Feldkirch, AT)

Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes

Speaker: Miss S. Jung (Erlangen, DE)

Access the full session

Diabetes and the heart

Speakers: Assistant Professor A. Malik, Doctor M. Jensen, Miss T. de Vries, Doctor I. Ikonomidis, Doctor A. Mader...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources